Convatec Group (LON:CTEC) Sets New 52-Week High – Time to Buy?

Convatec Group PLC (LON:CTEC – Get Free Report) hit a new 52-week high during trading on Monday. The stock traded as high as GBX 259.80 and last traded at GBX 258, with a volume of 8,874,752 shares trading hands. The stock had previously closed at GBX 257.40.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on CTEC. Peel Hunt restated an “add” rating and set a GBX 270 target price on shares of Convatec Group in a research report on Tuesday, August 4th. Jefferies Financial Group reaffirmed a “buy” rating and set a GBX 300 price target on shares of Convatec Group in a research report on Wednesday, August 5th. Berenberg Bank reduced their price objective on Convatec Group from GBX 340 to GBX 335 and set a “buy” rating for the company in a research note on Friday, September 11th. Deutsche Bank reiterated a “buy” rating and set a GBX 315 price objective on shares of Convatec Group in a research note on Wednesday, August 5th. Finally, Royal Bank Of Canada reissued an “outperform” rating and issued a GBX 315 price objective on shares of Convatec Group in a report on Monday, August 3rd. Eight research analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, Convatec Group has a consensus rating of “Moderate Buy” and an average target price of GBX 305.44.

Get Our Latest Research Report on Convatec Group

Convatec Group Stock Up 8.2%

The company has a current ratio of 1.93, a quick ratio of 0.96 and a debt-to-equity ratio of 121.83. The business has a fifty day simple moving average of GBX 231.57 and a two-hundred day simple moving average of GBX 224.26. The company has a market cap of £5.10 billion, a PE ratio of 43.06, a price-to-earnings-growth ratio of 0.93 and a beta of 0.77.

Insider Activity

In other Convatec Group news, insider Jens Viebke bought 24,400 shares of the business’s stock in a transaction on Tuesday, October 13th. The stock was bought at an average price of GBX 230 per share, with a total value of £56,120. 1.00% of the stock is owned by corporate insiders.

About Convatec Group

(Get Free Report)

ConvaTec Group PLC engages in the development, manufacturing, and sale of medical products, services, and technologies in Europe, North America, and internationally. The company offers advanced wound dressings and skin care products for the management of acute and chronic wounds resulting from various conditions, such as diabetes, and acute conditions resulting from traumatic injury and burns. It also provides ostomy care solutions, including devices, accessories, and services for people with a stoma resulting from colorectal cancer, inflammatory bowel disease, and bladder cancer.

Recommended Stories

Receive News & Ratings for Convatec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Convatec Group and related companies with MarketBeat.com's FREE daily email newsletter.